HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

D Skarlos Selected Research

Irinotecan (Camptosar)

7/2008Multicenter phase-II trial of irinotecan plus oxaliplatin [IROX regimen] in patients with poor-prognosis cancer of unknown primary: a hellenic cooperative oncology group study.
12/2007Combination chemotherapy with cisplatin, etoposide and irinotecan in patients with extensive small-cell lung cancer: A phase II study of the Hellenic Co-operative Oncology Group.
11/2005Phase I study of etoposide, cisplatin and irinotecan triplet in patients with advanced-stage small-cell lung cancer.
6/2005Irinotecan or oxaliplatin combined with leucovorin and 5-fluorouracil as first-line treatment in advanced colorectal cancer: a multicenter, randomized, phase II study.
1/2003A phase II study with CPT-11 plus leucovorin and bolus IV 5-fluorouracil in patients with advanced colorectal carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


D Skarlos Research Topics

Disease

12Breast Neoplasms (Breast Cancer)
07/2011 - 01/2000
8Neoplasms (Cancer)
07/2011 - 07/2001
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2011 - 02/2000
5Small Cell Lung Carcinoma (Small Cell Lung Cancer)
10/2016 - 11/2000
5Neoplasm Metastasis (Metastasis)
07/2008 - 07/2000
4Neutropenia
12/2007 - 02/2000
3Colorectal Neoplasms (Colorectal Cancer)
06/2005 - 02/2000
3Diarrhea
02/2005 - 02/2000
2Carcinoma (Carcinomatosis)
07/2008 - 09/2000
2Thrombocytopenia (Thrombopenia)
05/2008 - 02/2000
2Febrile Neutropenia
12/2007 - 07/2001
2Ovarian Neoplasms (Ovarian Cancer)
06/2007 - 11/2000
2Pain (Aches)
05/2005 - 01/2005
2Prostatic Neoplasms (Prostate Cancer)
01/2005 - 06/2003
2Renal Cell Carcinoma (Grawitz Tumor)
01/2002 - 08/2000
1Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
02/2012
1Nasopharyngeal Carcinoma
02/2012
1Anemia
02/2009
1Thymoma (Thymic Carcinoma)
07/2008
1Ovarian Epithelial Carcinoma
09/2007
1Pancreatic Neoplasms (Pancreatic Cancer)
05/2005
1Exanthema (Rash)
02/2005
1Sarcoma (Soft Tissue Sarcoma)
11/2004
1Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
03/2004
1Nonseminomatous germ cell tumor
03/2004
1Sepsis (Septicemia)
01/2003
1Bacteremia
01/2003
1Brain Neoplasms (Brain Tumor)
01/2002
1Melanoma (Melanoma, Malignant)
01/2002
1Acquired Immunodeficiency Syndrome (AIDS)
11/2000
1Kaposi Sarcoma (Kaposi's Sarcoma)
11/2000
1Peritoneal Neoplasms
09/2000
1Lymphoma (Lymphomas)
05/2000
1Glioma (Gliomas)
05/2000
1Non-Hodgkin Lymphoma (Lymphosarcoma)
05/2000
1Colonic Neoplasms (Colon Cancer)
04/2000
1Nausea
01/2000
1Constipation
01/2000
1Headache (Headaches)
01/2000
1Vomiting
01/2000

Drug/Important Bio-Agent (IBA)

15Paclitaxel (Taxol)FDA LinkGeneric
04/2011 - 02/2000
7GemcitabineFDA Link
04/2011 - 02/2000
7Fluorouracil (Carac)FDA LinkGeneric
11/2005 - 02/2000
6Cisplatin (Platino)FDA LinkGeneric
02/2012 - 07/2001
6Epirubicin (Ellence)FDA LinkGeneric
05/2008 - 01/2000
6Carboplatin (JM8)FDA LinkGeneric
01/2008 - 02/2000
5Irinotecan (Camptosar)FDA LinkGeneric
07/2008 - 01/2003
4Oxaliplatin (Eloxatin)FDA LinkGeneric
07/2008 - 02/2000
4Leucovorin (Folinic Acid)FDA Link
06/2005 - 02/2000
3Trastuzumab (Herceptin)FDA Link
07/2011 - 11/2001
3Vinorelbine (Navelbine)FDA LinkGeneric
04/2011 - 07/2001
3AnthracyclinesIBA
05/2009 - 05/2000
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2005 - 01/2001
3Docetaxel (Taxotere)FDA Link
01/2005 - 09/2001
2thiamine triphosphorate (TTP)IBA
07/2011 - 07/2001
2taxaneIBA
05/2009 - 05/2008
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
12/2007 - 07/2001
2Etoposide (VP 16)FDA LinkGeneric
12/2007 - 11/2005
2Topotecan (Hycamtin)FDA LinkGeneric
06/2007 - 06/2006
2Methotrexate (Mexate)FDA LinkGeneric
11/2005 - 01/2001
2Analgesics (Analgesic Drugs)IBA
05/2005 - 01/2005
2EstramustineFDA Link
01/2005 - 06/2003
2AndrogensIBA
01/2005 - 06/2003
2liposomal doxorubicin (Doxil)FDA Link
11/2004 - 11/2000
2Mitoxantrone (Novantrone)FDA LinkGeneric
02/2004 - 06/2003
2Temozolomide (Temodar)FDA LinkGeneric
01/2002 - 05/2000
2Vinblastine (Vinblastine Sulfate)FDA Link
01/2002 - 08/2000
2PlatinumIBA
07/2001 - 02/2000
1Biomarkers (Surrogate Marker)IBA
02/2012
1Formaldehyde (Formol)FDA Link
07/2011
1ParaffinIBA
07/2011
1ErythropoietinFDA Link
02/2009
1Erlotinib Hydrochloride (CP 358,774)FDA Link
07/2008
1ErbB Receptors (EGF Receptor)IBA
02/2005
1Gefitinib (Iressa)FDA Link
02/2005
1Zoledronic Acid (Zometa)FDA Link
01/2005
1Phosphates (Orthophosphate)IBA
01/2005
1VA 061 (VA061)IBA
01/2005
11-dodecylpyridoxal (PLD)IBA
11/2004
1TamoxifenFDA LinkGeneric
02/2004
1Hormones (Hormone)IBA
06/2003
1Alkylating AgentsIBA
01/2002
1Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2002
1Interferon-gamma (Interferon, gamma)IBA
01/2002
1Taxoids (Taxanes)IBA
07/2001
1Anti-Bacterial Agents (Antibiotics)IBA
07/2001
1InterferonsIBA
08/2000
1Levamisole (Decaris)FDA Link
04/2000
1Interferon alpha-2 (Roferon-A)FDA Link
04/2000
1altersolanol AIBA
04/2000
1antineoplaston A10 (A 10)IBA
02/2000

Therapy/Procedure

25Drug Therapy (Chemotherapy)
10/2016 - 01/2000
5Therapeutics
07/2011 - 02/2004
5Combination Drug Therapy (Combination Chemotherapy)
12/2007 - 02/2000
3Radiotherapy
10/2016 - 05/2000
2Chemoradiotherapy
02/2012 - 11/2007
2Adjuvant Chemotherapy
05/2009 - 01/2001
1Induction Chemotherapy
02/2012
1CMF regimen
01/2001
1Drug Tapering
02/2000